How Open-Source Technologies Will Transform Digital Clinical Trials
HIT Consultant
FEBRUARY 13, 2024
Likewise, when potentially lifesaving drugs are discovered, patient advocacy groups may petition to accelerate review timelines. A recent example is the September 2022 approval of RELYVRIO, a drug for ALS (Amyotrophic Lateral Sclerosis) or Lou Gehrig’s disease that slows the loss of physical function.
Let's personalize your content